Parallax Volatility Advisers’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-215,500
Closed -$2.15M 1445
2025
Q4
$2.15M Hold
215,500
﹤0.01% 932
2025
Q3
$1.93M Hold
215,500
﹤0.01% 937
2025
Q2
$2.03M Sell
215,500
-100,000
-32% -$882K ﹤0.01% 888
2025
Q1
$3.42M Sell
315,500
-84,500
-21% -$850K 0.01% 721
2024
Q4
$3.81M Buy
400,000
+43,300
+12% +$438K 0.01% 927
2024
Q3
$4.01M Buy
356,700
+109,000
+44% +$1.16M 0.01% 887
2024
Q2
$2.48M Buy
+247,700
New +$2.52M 0.01% 970
2023
Q4
Sell
-144,400
Closed -$1.31M 2136
2023
Q3
$1.31M Buy
144,400
+70,500
+95% +$845K ﹤0.01% 1254
2023
Q2
$899K Sell
73,900
-5,100
-6% -$56.8K ﹤0.01% 1440
2023
Q1
$982K Sell
79,000
-189,800
-71% -$3.49M ﹤0.01% 1513
2022
Q4
$5.17M Buy
268,800
+153,800
+134% +$3.25M 0.01% 1012
2022
Q3
$2.16M Buy
+115,000
New +$2.36M ﹤0.01% 1388

Other funds holding AHCO

Parallax Volatility Advisers's AHCO Position: Q4 2025 in Review

Parallax Volatility Advisers sold out of AdaptHealth (AHCO) in Q4 2025, closing a stake of 33,947 shares — an estimated $324K sold.

Parallax Volatility Advisers first reported a position in AHCO in Q4 2022 and held it in 7 quarters. The position peaked at $1.42M in Q4 2024. 231 funds tracked by Wall St. Rank hold AHCO as of Q4 2025.

  • Parallax Volatility Advisers reported no remaining AdaptHealth position as of Q4 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 33,947 AdaptHealth shares in Q4 2025, an estimated $324K.
  • Parallax Volatility Advisers first reported a position in AdaptHealth in Q4 2022 and held it in 7 quarters.
  • Parallax Volatility Advisers's AdaptHealth position peaked at $1.42M in Q4 2024.
  • 231 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2025.

Based on Parallax Volatility Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.